Cargando…
Evaluation of seven gene signature for predicting HCV recurrence post-liver transplantation
BACKGROUND: Orthotropic liver transplantation (OLT) offers a therapeutic choice for hepatocellular carcinoma (HCC) patients. The poor outcome of liver transplantation is HCV recurrence. Several genome-wide associated studies (GWAS) have reported many genetic variants to be associated with HCV recurr...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Berlin Heidelberg
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8581076/ https://www.ncbi.nlm.nih.gov/pubmed/34757522 http://dx.doi.org/10.1186/s43141-021-00266-4 |
_version_ | 1784596733452353536 |
---|---|
author | Salum, Ghada M. el Meguid, Mai Abd Abelhafez, Tawfeek H. Medhat, Eman Abdel Aziz, Ashraf O. Dawood, Reham |
author_facet | Salum, Ghada M. el Meguid, Mai Abd Abelhafez, Tawfeek H. Medhat, Eman Abdel Aziz, Ashraf O. Dawood, Reham |
author_sort | Salum, Ghada M. |
collection | PubMed |
description | BACKGROUND: Orthotropic liver transplantation (OLT) offers a therapeutic choice for hepatocellular carcinoma (HCC) patients. The poor outcome of liver transplantation is HCV recurrence. Several genome-wide associated studies (GWAS) have reported many genetic variants to be associated with HCV recurrence. Seven gene polymorphisms formed a cirrhosis risk score (CRS) signature that could be used to distinguish chronic HCV patients at high risk from those at low risk for cirrhosis in non-transplant patients. This study aims to examine the association of CRS score and other clinical parameters with the probability for HCC emergence and/or the rate of HCV recurrence following liver transplantation. RESULTS: Seven gene polymorphisms, forming the CRS, were genotyped by real-time PCR using allelic discrimination protocol in 199 end-stage liver disease patients (79 child A, 43 child B, and 77child C), comprising 106 patients who encountered liver transplantation. Recipient CRS scores were correlated with HCV recurrence (HCV-Rec) at the end of the third year after OLT. Around 81% (39) recipients with low steatosis (LS; < 3.5%) donor percentage revealed no HCV recurrence (non-Rec) (p<0.001). CRS score could distinguish between child A, child B, and child C only at the low-risk group. Among the HCV Rec group 27% (8/30), 40% (12/30), and 33% (10/30) fell into the high, moderate, and low CRS risk groups, respectively. Stepwise logistic regression evinced two features more likely to be seen in HCV-Rec patients: abnormal ALT [OR, 1.1; 95% CI, 1.02–1.2] and donor steatosis >3.5% [OR, 46.07; 95% CI, 1.5–1407.8]. CONCLUSIONS: Accordingly, the CRS score seems to be less useful to predict HCV recurrence after OLT. ALT and donor steatosis (exceed 3.5%) can significantly promote the HCV recurrence post-OLT. Moreover, the combination of MMF and CNI positively heightens HCV recurrence. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s43141-021-00266-4. |
format | Online Article Text |
id | pubmed-8581076 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | Springer Berlin Heidelberg |
record_format | MEDLINE/PubMed |
spelling | pubmed-85810762021-11-23 Evaluation of seven gene signature for predicting HCV recurrence post-liver transplantation Salum, Ghada M. el Meguid, Mai Abd Abelhafez, Tawfeek H. Medhat, Eman Abdel Aziz, Ashraf O. Dawood, Reham J Genet Eng Biotechnol Research BACKGROUND: Orthotropic liver transplantation (OLT) offers a therapeutic choice for hepatocellular carcinoma (HCC) patients. The poor outcome of liver transplantation is HCV recurrence. Several genome-wide associated studies (GWAS) have reported many genetic variants to be associated with HCV recurrence. Seven gene polymorphisms formed a cirrhosis risk score (CRS) signature that could be used to distinguish chronic HCV patients at high risk from those at low risk for cirrhosis in non-transplant patients. This study aims to examine the association of CRS score and other clinical parameters with the probability for HCC emergence and/or the rate of HCV recurrence following liver transplantation. RESULTS: Seven gene polymorphisms, forming the CRS, were genotyped by real-time PCR using allelic discrimination protocol in 199 end-stage liver disease patients (79 child A, 43 child B, and 77child C), comprising 106 patients who encountered liver transplantation. Recipient CRS scores were correlated with HCV recurrence (HCV-Rec) at the end of the third year after OLT. Around 81% (39) recipients with low steatosis (LS; < 3.5%) donor percentage revealed no HCV recurrence (non-Rec) (p<0.001). CRS score could distinguish between child A, child B, and child C only at the low-risk group. Among the HCV Rec group 27% (8/30), 40% (12/30), and 33% (10/30) fell into the high, moderate, and low CRS risk groups, respectively. Stepwise logistic regression evinced two features more likely to be seen in HCV-Rec patients: abnormal ALT [OR, 1.1; 95% CI, 1.02–1.2] and donor steatosis >3.5% [OR, 46.07; 95% CI, 1.5–1407.8]. CONCLUSIONS: Accordingly, the CRS score seems to be less useful to predict HCV recurrence after OLT. ALT and donor steatosis (exceed 3.5%) can significantly promote the HCV recurrence post-OLT. Moreover, the combination of MMF and CNI positively heightens HCV recurrence. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s43141-021-00266-4. Springer Berlin Heidelberg 2021-11-10 /pmc/articles/PMC8581076/ /pubmed/34757522 http://dx.doi.org/10.1186/s43141-021-00266-4 Text en © The Author(s) 2021 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . |
spellingShingle | Research Salum, Ghada M. el Meguid, Mai Abd Abelhafez, Tawfeek H. Medhat, Eman Abdel Aziz, Ashraf O. Dawood, Reham Evaluation of seven gene signature for predicting HCV recurrence post-liver transplantation |
title | Evaluation of seven gene signature for predicting HCV recurrence post-liver transplantation |
title_full | Evaluation of seven gene signature for predicting HCV recurrence post-liver transplantation |
title_fullStr | Evaluation of seven gene signature for predicting HCV recurrence post-liver transplantation |
title_full_unstemmed | Evaluation of seven gene signature for predicting HCV recurrence post-liver transplantation |
title_short | Evaluation of seven gene signature for predicting HCV recurrence post-liver transplantation |
title_sort | evaluation of seven gene signature for predicting hcv recurrence post-liver transplantation |
topic | Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8581076/ https://www.ncbi.nlm.nih.gov/pubmed/34757522 http://dx.doi.org/10.1186/s43141-021-00266-4 |
work_keys_str_mv | AT salumghadam evaluationofsevengenesignatureforpredictinghcvrecurrencepostlivertransplantation AT elmeguidmaiabd evaluationofsevengenesignatureforpredictinghcvrecurrencepostlivertransplantation AT abelhafeztawfeekh evaluationofsevengenesignatureforpredictinghcvrecurrencepostlivertransplantation AT medhateman evaluationofsevengenesignatureforpredictinghcvrecurrencepostlivertransplantation AT abdelazizashrafo evaluationofsevengenesignatureforpredictinghcvrecurrencepostlivertransplantation AT dawoodreham evaluationofsevengenesignatureforpredictinghcvrecurrencepostlivertransplantation |